DENVER--(BUSINESS WIRE)--Aug. 3, 2006-- Infectious Disease Programs Focused on Anti-bacterial Device Coatings, MRSA and VRSA Resistant Bacterial Strains, and Viral Infections Ceragenix Pharmaceuticals, Inc., a biopharmaceutical company focused on infectious disease and dermatology, today provided a mid-year update on its two major product development areas, dermatologic disorders and infectious diseases.
